Lung disease at high altitude

References

• West JB, Lahiri S, Maret KH, Peters RM Jr, Pizzo CJ. Barometric pressures at extreme altitudes on Mt. Everest: physiological significance. J. Appl. Physiol.54(5), 1188–1194 (1983).
   PubMed Web of Science ®Google Scholar
• Spieksma FT, Zuidema P, Leupen MJ. High altitude and house-dust mites. Br. Med. J.1(5740), 82–84 (1971).
   PubMedGoogle Scholar
• Bishop GA, Morris JA, Stedman DH et al. The effects of altitude on heavy-duty diesel truck on-road emissions. Environ. Sci. Technol.35(8), 1574–1578 (2001).
   PubMed Web of Science ®Google Scholar
• Luks AM, Swenson ER. Travel to high altitude with pre-existing lung disease. Eur. Respir. J.29(4), 770–792 (2007).
   PubMedGoogle Scholar
• Wagner PD, Sutton JR, Reeves JT et al. Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt. Everest. J. Appl. Physiol.63(6), 2348–2359 (1987).
   PubMed Web of Science ®Google Scholar
• Wagner PD, Wagner HE, Groves BM, Cymerman A, Houston CS. Hemoglobin P(50) during a simulated ascent of Mt. Everest, Operation Everest II. High Alt. Med. Biol.8(1), 32–42 (2007).
   PubMed Web of Science ®Google Scholar
• Canepa A, Chavez R, Hurtado A, Rotta A, Velasquez T. Pulmonary circulation at sea level and at high altitudes. J. Appl. Physiol.9(3), 328–336 (1956).
   PubMedGoogle Scholar
• Grunig E, Mereles D, Hildebrandt W et al. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J. Am. Coll. Cardiol.35(4), 980–987 (2000).
   PubMedGoogle Scholar
• Hultgren HN, Grover RF, Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation44(5), 759–770 (1971).
   PubMed Web of Science ®Google Scholar
• Kawashima A, Kubo K, Kobayashi T, Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high-altitude pulmonary edema. J. Appl. Physiol.67(5), 1982–1989 (1989).
   PubMedGoogle Scholar
• Hackett P, Roach RC. High-altitude medicine. In: Wilderness Medicine. Auerbach P (Ed.). Mosby, MO, USA, 2–36 (2007).
   Google Scholar
• Vock P, Brutsche MH, Nanzer A, Bärtsch P. Variable radiomorphologic data of high altitude pulmonary edema. Features from 60 patients. Chest100(5), 1306–1311 (1991).
   PubMedGoogle Scholar
• Bärtsch P, Maggiorini M, Ritter M et al. Prevention of high-altitude pulmonary edema by nifedipine. N. Engl. J. Med.325(18), 1284–1289 (1991).
   PubMed Web of Science ®Google Scholar
• Sophocles A Jr. High-altitude pulmonary edema in Vail, Colorado, 1975–1982. West J. Med.144(5), 569–573 (1986).
   PubMedGoogle Scholar
• Hultgren HN, Honigman B, Theis K, Nicholas D. High-altitude pulmonary edema at a ski resort. West J. Med.164(3), 222–227 (1996).
   PubMedGoogle Scholar
• Reeves J, Wagner J, Zafren K, Honigman B, Schoene R. Seasonal variation in barometric pressure and temperature in Summit County: effect on altitude illness. In: Hypoxia and Molecular Medicine. Sutton J, Houston C, Coates G (Eds). Charles S Houston, VT, USA, 275–281 (1993).
   Google Scholar
• Durmowicz AG, Noordeweir E, Nicholas R, Reeves JT. Inflammatory processes may predispose children to high-altitude pulmonary edema. J. Pediatr.130(5), 838–840 (1997).
   PubMedGoogle Scholar
• Hackett PH, Roach RC, Schoene RB, Harrison GL, Mills WJ Jr. Abnormal control of ventilation in high-altitude pulmonary edema. J. Appl. Physiol.64(3), 1268–1272 (1988).
   PubMed Web of Science ®Google Scholar
• Hohenhaus E, Paul A, McCullough RE, Kucherer H, Bärtsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur. Respir. J.8(11), 1825–1833 (1995).
   PubMedGoogle Scholar
• Matsuzawa Y, Fujimoto K, Kobayashi T et al. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J. Appl. Physiol.66(3), 1152–1157 (1989).
   PubMed Web of Science ®Google Scholar
• Hackett PH, Creagh CE, Grover RF et al. High-altitude pulmonary edema in persons without the right pulmonary artery. N. Engl. J. Med.302(19), 1070–1073 (1980).
   PubMed Web of Science ®Google Scholar
• Durmowicz AG. Pulmonary edema in 6 children with Down syndrome during travel to moderate altitudes. Pediatrics108(2), 443–447 (2001).
   PubMedGoogle Scholar
• Torrington KG. Recurrent high-altitude illness associated with right pulmonary artery occlusion from granulomatous mediastinitis. Chest96(6), 1422–1424 (1989).
   PubMedGoogle Scholar
• Naeije R, De Backer D, Vachiery J-L, De Vuyst P. High-altitude pulmonary edema with primary pulmonary hypertension. Chest110(1), 286–289 (1996).
   PubMedGoogle Scholar
• Bärtsch P, Mairbäurl H, Maggiorini M, Swenson ER. Physiological aspects of high-altitude pulmonary edema. J. Appl. Physiol.98(3), 1101–1110 (2005).
   PubMed Web of Science ®Google Scholar
• Swenson ER, Maggiorini M, Mongovin S et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA287(17), 2228–2235 (2002).
   PubMed Web of Science ®Google Scholar
• Sartori C, Allemann Y, Duplain H et al. Salmeterol for the prevention of high-altitude pulmonary edema. N. Engl. J. Med.346(21), 1631–1636 (2002).
   PubMed Web of Science ®Google Scholar
• Maggiorini M, Brunner-La Rocca HP, Peth S et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann. Intern. Med.145(7), 497–506 (2006).
   PubMed Web of Science ®Google Scholar
• Berg J, Ramanathan S, Swenson E. Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats. Wilderness Environ. Med.15, 32–37 (2004).
   PubMedGoogle Scholar
• Deem S, Hedges RG, Kerr ME, Swenson ER. Acetazolamide reduces hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs. Respir. Physiol.123(1–2), 109–119 (2000).
   PubMedGoogle Scholar
• Höhne C, Krebs MO, Seiferheld M et al. Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs. J. Appl. Physiol.97(2), 515–521 (2004).
   PubMedGoogle Scholar
• Teppema LJ, Balanos GM, Steinback CD et al. Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am. J. Respir. Crit. Care Med.175(3), 277–281 (2007).
   PubMed Web of Science ®Google Scholar
• Oelz O, Noti C, Ritter M, Jenni R, Bärtsch P. Nifedipine for high altitude pulmonary oedema. Lancet337(8740), 556 (1991).
   PubMedGoogle Scholar
• Fagenholz PJ, Gutman JA, Murray AF, Harris NS. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High Alt. Med. Biol.8(2), 139–146 (2007).
   PubMed Web of Science ®Google Scholar
• Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet2(7996), 1149–1155 (1976).
   PubMed Web of Science ®Google Scholar
• Honigman B, Theis MK, Koziol-McLain J et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann. Intern. Med.118(8), 587–592 (1993).
   PubMed Web of Science ®Google Scholar
• Roach RC, Bärtsch P, Oelz O, Hackett PH, Committee LLASC. The Lake Louise acute mountain sickness scoring system. In: Hypoxia and Molecular Medicine. Sutton JR, Houston CS, Coates G (Eds). Charles S Houston, VT, USA, 272–274 (1993).
   Google Scholar
• Grissom CK, Roach RC, Sarnquist FH, Hackett PH. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann. Intern. Med.116(6), 461–465 (1992).
   PubMedGoogle Scholar
• Bärtsch P, Swenson ER, Paul A, Julg B, Hohenhaus E. Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. High Alt. Med. Biol.3(4), 361–376 (2002).
   PubMedGoogle Scholar
• Hohenhaus E, Niroomand F, Goerre S et al. Nifedipine does not prevent acute mountain sickness. Am. J. Respir. Crit. Care Med.150(3), 857–860 (1994).
   PubMed Web of Science ®Google Scholar
• Moore LG, Harrison GL, McCullough RE et al. Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. J. Appl. Physiol.60(4), 1407–1412 (1986).
   PubMedGoogle Scholar
• Erba P, Anastasi S, Senn O, Maggiorirni M, Bloch KE. Acute mountain sickness is related to nocturnal hypoxemia but not to hypoventilation. Eur. Respir. J.24(2), 303–308 (2004).
   PubMedGoogle Scholar
• Roach RC, Maes D, Sandoval D et al. Exercise exacerbates acute mountain sickness at simulated high altitude. J. Appl. Physiol.88(2), 581–585 (2000).
   PubMedGoogle Scholar
• Sutton JR, Bryan AC, Gray GW et al. Pulmonary gas exchange in acute mountain sickness. Aviat. Space Environ. Med.47(10), 1032–1037 (1976).
   PubMedGoogle Scholar
• Ge RL, Matsuzawa Y, Takeoka M et al. Low pulmonary diffusing capacity in subjects with acute mountain sickness. Chest111(1), 58–64 (1997).
   PubMedGoogle Scholar
• Loeppky JA, Icenogle MV, Charlton GA et al. Hypoxemia and acute mountain sickness: which comes first? High Alt. Med. Biol.9(4), 271–279 (2008).
   PubMedGoogle Scholar
• Loeppky JA, Icenogle MV, Maes D et al. Early fluid retention and severe acute mountain sickness. J. Appl. Physiol.98(2), 591–597 (2005).
   PubMedGoogle Scholar
• Hackett PH, Rennie D. Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am. J. Med.67(2), 214–218 (1979).
   PubMed Web of Science ®Google Scholar
• Cremona G, Asnaghi R, Baderna P et al. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet359(9303), 303–309 (2002).
   PubMedGoogle Scholar
• Pappenheimer JR. Sleep and respiration of rats during hypoxia. J. Physiol.266(1), 191–207 (1977).
   PubMed Web of Science ®Google Scholar
• Megirian D, Ryan AT, Sherrey JH. An electrophysiological analysis of sleep and respiration of rats breathing different gas mixtures: diaphragmatic muscle function. Electroencephalogr. Clin. Neurophysiol.50(3–4), 303–313 (1980).
   PubMedGoogle Scholar
• West JB, Peters RM Jr, Aksnes G et al. Nocturnal periodic breathing at altitudes of 6,300 and 8,050 m. J. Appl. Physiol.61(1), 280–287 (1986).
   PubMedGoogle Scholar
• Przybylowski T, Ashirbaev A, Le Roux J, Zielinski J. Sleep and breathing at altitude of 3800 m – the acclimatization effect. Pneumonol. Alergol. Pol.71(5–6), 213–220 (2003).
   PubMedGoogle Scholar
• Mees K, de la Chaux R. Polygraphy of sleep at altitudes between 5300m and 7500m during an expedition to Mt. Everest (MedEx 2006). Wilderness Environ. Med.20(2), 161–165 (2009).
   PubMedGoogle Scholar
• Waggener TB, Brusil PJ, Kronauer RE, Gabel RA, Inbar GF. Strength and cycle time of high-altitude ventilatory patterns in unacclimatized humans. J. Appl. Physiol.56(3), 576–581 (1984).
   PubMedGoogle Scholar
• Fujimoto K, Matsuzawa Y, Hirai K et al. Irregular nocturnal breathing patterns high altitude in subjects susceptible to high-altitude pulmonary edema (HAPE): a preliminary study. Aviat. Space Environ. Med.60(8), 786–791 (1989).
   PubMedGoogle Scholar
• Normand H, Barragan M, Benoit O, Bailliart O, Raynaud J. Periodic breathing and O2 saturation in relation to sleep stages at high altitude. Aviat. Space Environ. Med.61(3), 229–235 (1990).
   PubMedGoogle Scholar
• Masuyama S, Kohchiyama S, Shinozaki T et al. Periodic breathing at high altitude and ventilatory responses to O2 and CO2. Jpn J. Physiol.39(4), 523–535 (1989).
   PubMedGoogle Scholar
• Chapman KR, Bruce EN, Gothe B, Cherniack NS. Possible mechanisms of periodic breathing during sleep. J. Appl. Physiol.64(3), 1000–1008 (1988).
   PubMedGoogle Scholar
• Sutton JR, Houston CS, Mansell AL et al. Effect of acetazolamide on hypoxemia during sleep at high altitude. N. Engl. J. Med.301(24), 1329–1331 (1979).
   PubMed Web of Science ®Google Scholar
• Hackett PH, Roach RC, Harrison GL, Schoene RB, Mills WJ Jr. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am. Rev. Respir. Dis.135(4), 896–898 (1987).
   PubMedGoogle Scholar
• Fischer R, Lang SM, Leitl M et al. Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude. Eur. Respir. J.23(1), 47–52 (2004).
   PubMedGoogle Scholar
• Dubowitz G. Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomised placebo controlled crossover trial. Br. Med. J.316(7131), 587–589 (1998).
   PubMedGoogle Scholar
• Nickol AH, Leverment J, Richards P et al. Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J. Sleep Res.15(4), 445–454 (2006).
   PubMedGoogle Scholar
• Roggla G, Moser B, Roggla M. Effect of temazepam on ventilatory response at moderate altitude. Br. Med. J.320(7226), 56 (2000).
   PubMed Web of Science ®Google Scholar
• Nicholson AN, Smith PA, Stone BM, Bradwell AR, Coote JH. Altitude insomnia: studies during an expedition to the Himalayas. Sleep11(4), 354–361 (1988).
   PubMedGoogle Scholar
• Beaumont M, Batejat D, Coste O et al. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m. Neuropsychobiology49(3), 154–162 (2004).
   PubMedGoogle Scholar
• Goldenberg F, Richalet JP, Onnen I, Antezana AM. Sleep apneas and high altitude newcomers. Int. J. Sports Med.13(Suppl. 1), S34–S36 (1992).
   PubMed Web of Science ®Google Scholar
• Luks AM, van Melick H, Batarse RR et al. Room oxygen enrichment improves sleep and subsequent day-time performance at high altitude. Respir. Physiol.113(3), 247–258 (1998).
   PubMedGoogle Scholar
• West JB. Potential use of oxygen enrichment of room air in mountain resorts. High Alt. Med. Biol.3(1), 59–64 (2002).
   PubMedGoogle Scholar
• Leon-Velarde F, Maggiorini M, Reeves JT et al. Consensus statement on chronic and subacute high altitude diseases. High Alt. Med. Biol.6(2), 147–157 (2005).
   PubMed Web of Science ®Google Scholar
• Gupta ML, Rao KS, Anand IS, Banerjee AK, Boparai MS. Lack of smooth muscle in the small pulmonary arteries of the native Ladakhi. Is the Himalayan highlander adapted? Am. Rev. Respir. Dis.145(5), 1201–1204 (1992).
   PubMedGoogle Scholar
• Groves BM, Droma T, Sutton JR et al. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J. Appl. Physiol.74(1), 312–318 (1993).
   PubMedGoogle Scholar
• Wu TY. Chronic mountain sickness on the Qinghai–Tibetan plateau. Chin. Med. J. (Engl.)118(2), 161–168 (2005).
   PubMedGoogle Scholar
• Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation115(9), 1132–1146 (2007).
   PubMed Web of Science ®Google Scholar
• Maignan M, Rivera-Ch M, Privat C et al. Pulmonary pressure and cardiac function in chronic mountain sickness patients. Chest135(2), 499–504 (2009).
   PubMedGoogle Scholar
• West JB, Schoene RB, Milledge JS. High Altitude Medicine and Physiology. Hodder Education, London, UK (2007).
   Google Scholar
• Pei SX, Chen XJ, Si Ren BZ et al. Chronic mountain sickness in Tibet. Q. J. Med.71(266), 555–574 (1989).
   PubMedGoogle Scholar
• Leon-Velarde F, Ramos MA, Hernandez JA et al. The role of menopause in the development of chronic mountain sickness. Am J. Physiol.272(1 Pt 2), R90–R94 (1997).
   Google Scholar
• Leon-Velarde F, Gamboa A, Rivera-Ch M, Palacios JA, Robbins PA. Selected contribution: peripheral chemoreflex function in high-altitude natives and patients with chronic mountain sickness. J. Appl. Physiol.94(3), 1269–1278; discussion 1253–1264 (2003).
   PubMedGoogle Scholar
• Moore JP, Claydon VE, Norcliffe LJ et al. Carotid baroreflex regulation of vascular resistance in high-altitude Andean natives with and without chronic mountain sickness. Exp. Physiol.91(5), 907–913 (2006).
   PubMedGoogle Scholar
• Arregui A, Leon-Velarde F, Cabrera J et al. Migraine, polycythemia and chronic mountain sickness. Cephalalgia14(5), 339–341 (1994).
   PubMedGoogle Scholar
• Kronenberg RS, Drage CW. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J. Clin. Invest.52(8), 1812–1819 (1973).
   PubMed Web of Science ®Google Scholar
• Cruz JC, Diaz C, Marticorena E, Hilario V. Phlebotomy improves pulmonary gas exchange in chronic mountain polycythemia. Respiration38(6), 305–313 (1979).
   PubMedGoogle Scholar
• Winslow RM, Monge CC, Brown EG et al. Effects of hemodilution on O2 transport in high-altitude polycythemia. J. Appl. Physiol.59(5), 1495–1502 (1985).
   PubMedGoogle Scholar
• Manier G, Guenard H, Castaing Y, Varene N, Vargas E. Pulmonary gas exchange in Andean natives with excessive polycythemia – effect of hemodilution. J. Appl. Physiol.65(5), 2107–2117 (1988).
   PubMedGoogle Scholar
• Keyl C, Schneider A, Gamboa A et al. Autonomic cardiovascular function in high-altitude Andean natives with chronic mountain sickness. J. Appl. Physiol.94(1), 213–219 (2003).
   PubMedGoogle Scholar
• Kryger M, Glas R, Jackson D et al. Impaired oxygenation during sleep in excessive polycythemia of high altitude: improvement with respiratory stimulation. Sleep1(1), 3–17 (1978).
   PubMed Web of Science ®Google Scholar
• Richalet JP, Rivera M, Bouchet P et al. Acetazolamide: a treatment for chronic mountain sickness. Am. J. Respir. Crit. Care Med.172(11), 1427–1433 (2005).
   PubMed Web of Science ®Google Scholar
• Richalet JP, Rivera-Ch M, Maignan M et al. Acetazolamide for Monge’s disease: efficiency and tolerance of 6-month treatment. Am. J. Respir. Crit. Care Med.177(12), 1370–1376 (2008).
   PubMedGoogle Scholar
• Rivera-Ch M, Huicho L, Bouchet P, Richalet JP, Leon-Velarde F. Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. Respir. Physiol. Neurobiol.162(3), 184–189 (2008).
   PubMedGoogle Scholar
• Vargas M, Leon-Velarde F, Monge CC, Orozco E, Rey L. Enalapril in the treatment of chronic mountain sickness. Wilderness Environ. Med.7(2), 193–194 (1996).
   PubMedGoogle Scholar
• Plata R, Cornejo A, Arratia C et al. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial. Lancet359(9307), 663–666 (2002).
   PubMed Web of Science ®Google Scholar
• Wu DC, Liu YR. High altitude heart disease. Chin. J. Pediatr.6, 348 (1955).
   Google Scholar
• Ge RL, Helun G. Current concept of chronic mountain sickness: pulmonary hypertension-related high-altitude heart disease. Wilderness Environ. Med.12(3), 190–194 (2001).
   PubMedGoogle Scholar
• Anand IS, Malhotra RM, Chandrashekhar Y et al. Adult subacute mountain sickness – a syndrome of congestive heart failure in man at very high altitude. Lancet335(8689), 561–565 (1990).
   PubMedGoogle Scholar
• Arias-Stella J, Saldana M. The terminal portion of the pulmonary arterial tree in people native to high altitudes. Circulation28, 915–925 (1963).
   PubMed Web of Science ®Google Scholar
• Li JB, Sui GJ. Pathological findings in high altitude heart disease. In: Applied High Altitude Medicine. Tibet Press, Lhasa, Tibet, 288–305 (1984).
   Google Scholar
• Wu TY. An investigation on high altitude heart disease. Zhonghua Yi Xue Za Zhi63(2), 90–92 (1983).
   PubMedGoogle Scholar
• Li YD, Ji L. An analysis of 500 cases of adult high altitude heart disease. Chin. J. Int. Med.28, 173 (1989).
   Google Scholar
• Antezana AM, Antezana G, Aparicio O et al. Pulmonary hypertension in high-altitude chronic hypoxia: response to nifedipine. Eur. Respir. J.12(5), 1181–1185 (1998).
   PubMedGoogle Scholar
• Richalet JP, Gratadour P, Robach P et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am. J. Respir. Crit. Care Med.171(3), 275–281 (2005).
   PubMed Web of Science ®Google Scholar
• Aldashev AA, Kojonazarov BK, Amatov TA et al. Phosphodiesterase type 5 and high altitude pulmonary hypertension. Thorax60(8), 683–687 (2005).
   PubMed Web of Science ®Google Scholar
• Rios B, Driscoll DJ, McNamara DG. High-altitude pulmonary edema with absent right pulmonary artery. Pediatrics75(2), 314–317 (1985).
   PubMedGoogle Scholar
• Nakagawa S, Kubo K, Koizumi T, Kobayashi T, Sekiguchi M. High-altitude pulmonary edema with pulmonary thromboembolism. Chest103(3), 948–950 (1993).
   PubMed Web of Science ®Google Scholar
• Das BB, Wolfe RR, Chan KC et al. High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude. Arch. Pediatr. Adolesc. Med.158(12), 1170–1176 (2004).
   PubMedGoogle Scholar
• Richalet JP, Chenivesse C, Larmignat P, Meille L. High altitude pulmonary edema, down syndrome, and obstructive sleep apneas. High Alt. Med. Biol.9(2), 179–181 (2008).
   PubMedGoogle Scholar
• Anand AC, Jha SK, Saha A, Sharma V, Adya CM. Thrombosis as a complication of extended stay at high altitude. Natl Med. J. India14(4), 197–201 (2001).
   PubMed Web of Science ®Google Scholar
• Ashraf H, Javed A, Ashraf S. Pulmonary embolism at high altitude and hyperhomocysteinemia. J. Coll. Physicians Surg. Pak.16, 71–73 (2006).
   PubMedGoogle Scholar
• Boulos P, Kouroukis C, Blake G. Superior sagittal sinus thrombosis occurring at high altitude associated with protein C deficiency. Acta Haematol.102, 104–106 (1999).
   PubMedGoogle Scholar
• Heffner JE, Sahn SA. High-altitude pulmonary infarction. Arch. Intern. Med.141(12), 1721 (1981).
   PubMedGoogle Scholar
• Schreijer AJ, Cannegieter SC, Meijers JC et al. Activation of coagulation system during air travel: a crossover study. Lancet367(9513), 832–838 (2006).
   PubMed Web of Science ®Google Scholar
• Van Patot M, Hill A, Dingman C et al. Risk of impaired coagulation in warfarin patients ascending to altitude (>2400 m). High Alt. Med. Biol.7(1), 39–46 (2006).
   PubMedGoogle Scholar
• Graham WG, Houston CS. Short-term adaptation to moderate altitude. Patients with chronic obstructive pulmonary disease. JAMA240(14), 1491–1494 (1978).
   PubMedGoogle Scholar
• Dillard TA, Berg BW, Rajagopal KR, Dooley JW, Mehm WJ. Hypoxemia during air travel in patients with chronic obstructive pulmonary disease. Ann. Intern. Med.111(5), 362–367 (1989).
   PubMed Web of Science ®Google Scholar
• Berg BW, Dillard TA, Rajagopal KR, Mehm WJ. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest101(3), 638–641 (1992).
   PubMedGoogle Scholar
• Christensen CC, Ryg M, Refvem OK, Skjonsberg OH. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. Eur. Respir. J.15(4), 635–639 (2000).
   PubMed Web of Science ®Google Scholar
• Seccombe LM, Kelly PT, Wong CK et al. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax59(11), 966–970 (2004).
   PubMedGoogle Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.152(5 Pt 2), S77–S121 (1995).
   PubMed Web of Science ®Google Scholar
• Committee BTSSoC. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax57(4), 289–304 (2002).
   PubMed Web of Science ®Google Scholar
• Gong H Jr, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am. Rev. Respir. Dis.130(6), 980–986 (1984).
   PubMed Web of Science ®Google Scholar
• Dine CJ, Kreider ME. Hypoxia altitude simulation test. Chest133(4), 1002–1005 (2008).
   PubMedGoogle Scholar
• Dillard TA, Moores LK, Bilello KL, Phillips YY. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest107(2), 352–357 (1995).
   PubMed Web of Science ®Google Scholar
• Astin TW, Penman RW. Airway obstruction due to hypoxemia in patients with chronic lung disease. Am. Rev. Respir. Dis.95(4), 567–575 (1967).
   PubMedGoogle Scholar
• Libby DM, Briscoe WA, King TK. Relief of hypoxia-related bronchoconstriction by breathing 30 per cent oxygen. Am. Rev. Respir. Dis.123(2), 171–175 (1981).
   PubMed Web of Science ®Google Scholar
• Koskela HO, Koskela AK, Tukiaineu HO. Bronchoconstriction due to cold weather in COPD. The roles of direct airway effects and cutaneous reflex mechanisms. Chest110(3), 632–636 (1996).
   PubMed Web of Science ®Google Scholar
• Finkelstein S, Tomashefski JF, Shillito FH. Pulmonary mechanics at altitude in normal and obstructive lung disease patients. Aerosp. Med.36, 880–884 (1965).
   PubMedGoogle Scholar
• Dillard TA, Rajagopal KR, Slivka WA et al. Lung function during moderate hypobaric hypoxia in normal subjects and patients with chronic obstructive pulmonary disease. Aviat. Space Environ. Med.69(10), 979–985 (1998).
   PubMedGoogle Scholar
• Parker GW, Stonehill RB. Further considerations of the roentgenologic evaluation of flying personnel at simulated altitude. Aerosp. Med.32, 501–504 (1961).
   PubMedGoogle Scholar
• Yanda RL, Herschensohn HL. Changes in lung volumes of emphysema patients upon short exposures to simulated altitude of 18,000 feet. Aerosp. Med.35, 1201–1203 (1964).
   PubMedGoogle Scholar
• Tomashefski JF, Feeley DR, Shillito FH. Effects of altitude on emphysematous blebs and bullae. Aerosp. Med.37(11), 1158–1162 (1966).
   PubMedGoogle Scholar
• Pollock-BarZiv S, Cohen MM, Downey GP et al. Air travel in women with lymphangioleiomyomatosis. Thorax62(2), 176–180 (2007).
   PubMedGoogle Scholar
• Moore LG, Rohr AL, Maisenbach JK, Reeves JT. Emphysema mortality is increased in Colorado residents at high altitude. Am. Rev. Respir. Dis.126(2), 225–228 (1982).
   PubMed Web of Science ®Google Scholar
• Coultas DB, Samet JM, Wiggins CL. Altitude and mortality from chronic obstructive lung disease in New Mexico. Arch. Environ. Health39(5), 355–359 (1984).
   PubMed Web of Science ®Google Scholar
• Mador MJ, Kufel TJ, Pineda LA, Sharma GK. Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.161(1), 118–123 (2000).
   PubMed Web of Science ®Google Scholar
• Lewis MI, Belman MJ, Monn SA, Elashoff JD, Koerner SK. The relationship between oxygen consumption and work rate in patients with airflow obstruction. Chest106(2), 366–372 (1994).
   PubMed Web of Science ®Google Scholar
• West JB, Boyer SJ, Graber DJ et al. Maximal exercise at extreme altitudes on Mount Everest. J. Appl. Physiol.55(3), 688–698 (1983).
   PubMed Web of Science ®Google Scholar
• Kennedy TP, Michael JR, Huang CK et al. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am. Rev. Respir. Dis.129(4), 544–551 (1984).
   PubMedGoogle Scholar
• Burghuber OC. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease. Respiration52(2), 86–93 (1987).
   PubMedGoogle Scholar
• Gourgoulianis KI, Brelas N, Hatziparasides G, Papayianni M, Molyvdas PA. The influence of altitude in bronchial asthma. Arch. Med. Res.32(5), 429–431 (2001).
   PubMed Web of Science ®Google Scholar
• Vargas MH, Sienra-Monge JJ, Diaz-Mejia G, DeLeon-Gonzalez M. Asthma and geographical altitude: an inverse relationship in Mexico. J. Asthma36(6), 511–517 (1999).
   PubMed Web of Science ®Google Scholar
• Boner AL, Peroni DG, Piacentini GL, Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin. Exp. Allergy23(12), 1021–1026 (1993).
   PubMed Web of Science ®Google Scholar
• Grootendorst DC, Dahlen SE, Van Den Bos JW et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin. Exp. Allergy31(3), 400–408 (2001).
   PubMed Web of Science ®Google Scholar
• Simon HU, Grotzer M, Nikolaizik WH, Blaser K, Schoni MH. High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma. Pediatr. Pulmonol.17(5), 304–311 (1994).
   PubMed Web of Science ®Google Scholar
• Dagg KD, Thomson LJ, Clayton RA, Ramsay SG, Thomson NC. Effect of acute alterations in inspired oxygen tension on methacholine induced bronchoconstriction in patients with asthma. Thorax52(5), 453–457 (1997).
   PubMedGoogle Scholar
• Denjean A, Roux C, Herve P et al. Mild isocapnic hypoxia enhances the bronchial response to methacholine in asthmatic subjects. Am. Rev. Respir. Dis.138(4), 789–793 (1988).
   PubMedGoogle Scholar
• Eckert DJ, Catcheside PG, Smith JH, Frith PA, McEvoy RD. Hypoxia suppresses symptom perception in asthma. Am. J. Respir. Crit. Care Med.169(11), 1224–1230 (2004).
   PubMedGoogle Scholar
• Alberts WM, Colice GC, Hammond MD, Goldman AL. Effect of mild hypoxemia on bronchial responsiveness. Ann. Allergy65(3), 189–193 (1990).
   PubMedGoogle Scholar
• Saito H, Nishimura M, Shinano H et al. Effect of mild hypoxia on airway responsiveness to methacholine in subjects with airway hyperresponsiveness. Chest116(6), 1653–1658 (1999).
   PubMedGoogle Scholar
• Nielsen TM, Pedersen OF. The effect of CO2 on peripheral airways. Acta Physiol. Scand.98(2), 192–199 (1976).
   PubMedGoogle Scholar
• van den Elshout FJ, van Herwaarden CL, Folgering HT. Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects. Thorax46(1), 28–32 (1991).
   PubMed Web of Science ®Google Scholar
• Ahmed T, Danta I. Effect of cold air exposure and exercise on nonspecific bronchial reactivity. Chest93(6), 1132–1136 (1988).
   PubMed Web of Science ®Google Scholar
• Kaminsky DA, Irvin CG, Gurka DA et al. Peripheral airways responsiveness to cool, dry air in normal and asthmatic individuals. Am. J. Respir. Crit. Care Med.152(6 Pt 1), 1784–1790 (1995).
   PubMed Web of Science ®Google Scholar
• Zeitoun M, Wilk B, Matsuzaka A et al. Facial cooling enhances exercise-induced bronchoconstriction in asthmatic children. Med. Sci. Sports Exerc.36(5), 767–771 (2004).
   PubMed Web of Science ®Google Scholar
• Larsson K, Ohlsen P, Larsson L et al. High prevalence of asthma in cross country skiers. Br. Med. J.307(6915), 1326–1329 (1993).
   PubMed Web of Science ®Google Scholar
• Pohjantahti H, Laitinen J, Parkkari J. Exercise-induced bronchospasm among healthy elite cross country skiers and non-athletic students. Scand. J. Med. Sci. Sports15(5), 324–328 (2005).
   PubMed Web of Science ®Google Scholar
• Durand F, Kippelen P, Ceugniet F et al. Undiagnosed exercise-induced bronchoconstriction in ski-mountaineers. Int. J. Sports Med.26(3), 233–237 (2005).
   PubMed Web of Science ®Google Scholar
• Allegra L, Cogo A, Legnani D et al. High altitude exposure reduces bronchial responsiveness to hypo-osmolar aerosol in lowland asthmatics. Eur. Respir. J.8(11), 1842–1846 (1995).
   PubMed Web of Science ®Google Scholar
• Cogo A, Basnyat B, Legnani D, Allegra L. Bronchial asthma and airway hyperresponsiveness at high altitude. Respiration64(6), 444–449 (1997).
   PubMed Web of Science ®Google Scholar
• Louie D, Pare PD. Physiological changes at altitude in nonasthmatic and asthmatic subjects. Can. Respir. J.11(3), 197–199 (2004).
   PubMedGoogle Scholar
• Stokes S, Kalson N, Earl M et al. Bronchial asthma on Mount Kilimanjaro is not a disadvantage. Thorax63(10), 936–937 (2008).
   PubMedGoogle Scholar
• Juniper EF, Latimer KM, Morris MM, Roberts RS, Hargreave FE. Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium. J. Allergy Clin. Immunol.78(3 Pt 1), 387–391 (1986).
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Mason NP, Barry PW et al. Effect of altitude on spirometric parameters and the performance of peak flow meters. Thorax51(2), 175–178 (1996).
   PubMedGoogle Scholar
• Rose DM, Fleck B, Thews O, Kamin WE. Blood gas-analyses in patients with cystic fibrosis to estimate hypoxemia during exposure to high altitudes in a hypobaric-chamber. Eur. J. Med. Res.5(1), 9–12 (2000).
   PubMedGoogle Scholar
• Fischer R, Lang SM, Bruckner K et al. Lung function in adults with cystic fibrosis at altitude: impact on air travel. Eur. Respir. J.25(4), 718–724 (2005).
   PubMedGoogle Scholar
• Kamin W, Fleck B, Rose DM, Thews O, Thielen W. Predicting hypoxia in cystic fibrosis patients during exposure to high altitudes. J. Cyst. Fibros.5(4), 223–228 (2006).
   PubMedGoogle Scholar
• Speechly-Dick ME, Rimmer SJ, Hodson ME. Exacerbations of cystic fibrosis after holidays at high altitude – a cautionary tale. Respir. Med.86(1), 55–56 (1992).
   PubMedGoogle Scholar
• Buchdahl RM, Babiker A, Bush A, Cramer D. Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax56(11), 877–879 (2001).
   PubMedGoogle Scholar
• Christensen CC, Ryg MS, Refvem OK, Skjonsberg OH. Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease. Eur. Respir. J.20(2), 300–305 (2002).
   PubMedGoogle Scholar
• Bergofsky EH. Respiratory failure in disorders of the thoracic cage. Am. Rev. Respir. Dis.119(4), 643–669 (1979).
   PubMedGoogle Scholar
• Herry I, Iung B, Piechaud JY et al. Cardiac cause of hypoxaemia in a kyphoscoliotic patient. Eur. Respir. J.14(6), 1433–1434 (1999).
   PubMedGoogle Scholar
• Noble JS, Davidson JA. Cor pulmonale presenting in a patient with congenital kyphoscoliosis following intercontinental air travel. Anaesthesia54(4), 361–363 (1999).
   PubMedGoogle Scholar
• Kelly PT, Swanney MP, Seccombe LM et al. Predicting the response to air travel in passengers with non-obstructive lung disease: are the current guidelines appropriate? Respirology14(4), 567–573 (2009).
   PubMedGoogle Scholar
• Burgess KR, Cooper J, Rice A et al. Effect of simulated altitude during sleep on moderate-severity OSA. Respirology11(1), 62–69 (2006).
   PubMedGoogle Scholar
• Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am. J. Med. Sci.321(4), 225–236 (2001).
   PubMed Web of Science ®Google Scholar
• Kessler R, Chaouat A, Schinkewitch P et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest120(2), 369–376 (2001).
   PubMed Web of Science ®Google Scholar
• Toff NJ. Hazards of air travel for the obese: Miss Pickwick and the Boeing 747. J. R. Coll. Physicians Lond.27(4), 375–376 (1993).
   PubMedGoogle Scholar
• Ri-Li G, Chase PJ, Witkowski S et al. Obesity: associations with acute mountain sickness. Ann. Intern. Med.139(4), 253–257 (2003).
   PubMed Web of Science ®Google Scholar
• Burgess KR, Johnson P, Edwards N, Cooper J. Acute mountain sickness is associated with sleep desaturation at high altitude. Respirology9(4), 485–492 (2004).
   PubMedGoogle Scholar
• Valencia-Flores M, Rebollar V, Santiago V et al. Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. Int. J. Obes. Relat. Metab. Disord.28(9), 1174–1180 (2004).
   PubMed Web of Science ®Google Scholar
• Lyons HA, Huang CT. Therapeutic use of progesterone in alveolar hypoventilation associated with obesity. Am. J. Med.44(6), 881–888 (1968).
   PubMedGoogle Scholar
• Sutton FD Jr, Zwillich CW, Creagh CE, Pierson DJ, Weil JV. Progesterone for outpatient treatment of Pickwickian syndrome. Ann. Intern. Med.83(4), 476–479 (1975).
   PubMed Web of Science ®Google Scholar
• Serebrovskaya T, Karaban I, Mankovskaya I et al. Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration65(1), 28–33 (1998).
   PubMed Web of Science ®Google Scholar
• Carroll JE, Zwillich CW, Weil JV. Ventilatory response in myotonic dystrophy. Neurology27(12), 1125–1128 (1977).
   PubMedGoogle Scholar
• Finnimore AJ, Jackson RV, Morton A, Lynch E. Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function. Thorax49(1), 66–70 (1994).
   PubMedGoogle Scholar
• Smith PE, Calverley PM, Edwards RH. Hypoxemia during sleep in Duchenne muscular dystrophy. Am. Rev. Respir. Dis.137(4), 884–888 (1988).
   PubMedGoogle Scholar
• Khan Y, Heckmatt JZ. Obstructive apnoeas in Duchenne muscular dystrophy. Thorax49(2), 157–161 (1994).
   PubMed Web of Science ®Google Scholar
• Sandham JD, Shaw DT, Guenter CA. Acute supine respiratory failure due to bilateral diaphragmatic paralysis. Chest72(1), 96–98 (1977).
   PubMed Web of Science ®Google Scholar
• Kumar N, Folger WN, Bolton CF. Dyspnea as the predominant manifestation of bilateral phrenic neuropathy. Mayo Clin. Proc.79(12), 1563–1565 (2004).
   PubMed Web of Science ®Google Scholar
• Benditt JO. Management of pulmonary complications in neuromuscular disease. Phys. Med. Rehabil. Clin. N. Am.9(1), 167–185 (1998).
   PubMedGoogle Scholar
• Hackett PH, Rennie D, Hofmeister SE et al. Fluid retention and relative hypoventilation in acute mountain sickness. Respiration43(5), 321–329 (1982).
   PubMed Web of Science ®Google Scholar
• Wade JG, Larson CP Jr, Hickey RF, Ehrenfeld WK, Severinghaus JW. Effect of carotid endarterectomy on carotid chemoreceptor and baroreceptor function in man. N. Engl. J. Med.282(15), 823–829 (1970).
   PubMed Web of Science ®Google Scholar
• Lugliani R, Whipp BJ, Seard C, Wasserman K. Effect of bilateral carotid-body resection on ventilatory control at rest and during exercise in man. N. Engl. J. Med.285(20), 1105–1111 (1971).
   PubMed Web of Science ®Google Scholar
• Roeggla G, Roeggla M, Wagner A, Laggner AN. Poor ventilatory response to mild hypoxia may inhibit acclimatization at moderate altitude in elderly patients after carotid surgery. Br. J. Sports Med.29(2), 110–112 (1995).
   PubMedGoogle Scholar
• Basnyat B. Neck irradiation or surgery may predispose to severe acute mountain sickness. J. Travel. Med.9(2), 105 (2002).
   PubMedGoogle Scholar
• Rathat C, Richalet JP, Larmignat P, Henry J. Neck irradiation by cobalt therapy and susceptibility to acute mountain sickness. J. Wilderness Med.4(2), 231–232 (1993).
   Google Scholar
• Basnyat B, Litch J. Another patient with neck irradiation and increased susceptibility to acute mountain sickness. Wilderness Environ. Med.8(3), 176 (1997).
   PubMedGoogle Scholar
• White DP, Zwillich CW, Pickett CK et al. Central sleep apnea. Improvement with acetazolamide therapy. Arch. Intern. Med.142(10), 1816–1819 (1982).
   PubMed Web of Science ®Google Scholar